BioSpace News Archive

Creatv MicroTech, a privately-held biotechnology company has pioneered a blood test for the universal screening of early stage cancer. They will present their initial clinical data showing the ability to identify invasive cancer with 87% accuracy.

In this report, Persistence Market Research (PMR) delivers key insights on the global animal parasiticides market in its published report, titled “Animal Parasiticides Market: Global Industry Analysis and Forecast, 2016–2026.”

According to the latest market report published by Persistence Market Research, titled “Global Market Study on Infectious Diseases Diagnostics: Increasing Demand for Evidence-Based Treatment to Boost Demand for Infectious Diagnostic Testing during Forecast Period”.

Persistence Market Research delivers key insights on the global lysosomal storage diseases therapeutics market in a new report titled, “Lysosomal Storage Diseases Therapeutics Market: Global Industry Analysis and Forecast, 2016–2026”.

Reaching the revenues of over US$ 6 Bn at the end of 2019, the global neuropathic pain management market is projected for a healthy CAGR during the forecast period (2019 – 2029).

Newly Available Publication Synthesizes Relevant Guidance from Multiple Federal and State Agencies

Persistence Market Research delivers key insights on the global peripherally inserted central catheters market in its published report titled “Global Market Study on Peripherally Inserted Central Catheters: Power Injected Peripherally Inserted Central Catheters Product Type Segment to Dominate the Market Through 2024 .”

After receiving more than 100 applications, NASA’s Jet Propulsion Laboratory in Southern California has selected eight U.S. manufacturers to make a new ventilator tailored for coronavirus patients.

According to the latest market report published by Persistence Market Research titled Surgical Dental Loupes and Camera Market, the global Surgical Dental Loupes and Camera Market is projected to expand at a CAGR of 9.5% during the forecast period (2016-2024).

Mylan N.V. (NASDAQ: MYL) today announced that the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan in inter partes review (IPR) proceedings finding all challenged claims of Sanofi’s Lantus® SoloSTAR® device patents, U.S. Patent Nos. 8,603,044, 8,992,486, and 9,526,844 unpatentable.